eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
7.32
+0.01 (0.10%)
Mar 9, 2026, 1:49 PM EDT - Market open
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $61.49 million as of March 9, 2026. Its market cap has decreased by -38.89% in one year.
Market Cap
61.49M
Enterprise Value
57.65M
1-Year Change
-38.89%
Ranking
Category
Stock Price
$7.32
Market Cap Chart
Since November 13, 2024, eXoZymes's market cap has decreased from $70.30M to $61.49M, a decrease of -12.53%. That is a compound annual growth rate of -9.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 61.43M | -32.80% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Q32 Bio | 65.66M |
| TScan Therapeutics | 63.56M |
| ImageneBio | 62.84M |
| Mereo BioPharma Group | 62.71M |
| NeurAxis | 60.83M |
| Instil Bio | 60.16M |
| Spruce Biosciences | 59.80M |
| Grace Therapeutics | 59.73M |